FDA approves once-monthly Abilify for schizophrenia - Reuters

[INCIID News Feed]

Fort Mills Times
<img alt="" height="1" width="1" />
FDA approves once-monthly Abilify for schizophrenia
Reuters
Thu Feb 28, 2013 7:26pm EST. (Reuters) - Regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug group Lundbeck.
Otsuka, Lundbeck Win Approval for Monthly Abilify ShotBloomberg
Lundbeck and Otsuka&#39;s once-monthly schizophrenia drug advantageous though ...Financial Times
FDA approves once-monthly Abilify Maintena (aripiprazole) for extended-release ...GlobeNewswire (press release)

all 4 news articles &raquo;


More...